Search PubMed⌕ Search

PubMed · 11630274

[Not Available].

Abstract

In studying the genesis of 'Generalplan Ost' one can elucidate the alliance of academic research and military expansion in Nazi Germany in a unique way. By 'Generalplan Ost' we understand the total German planning effort in transforming the territories of Poland, the Baltic republics and Soviet Union, which were occupied since the beginning of World War II. In this scientists were not only provided with ample opportunities for research by the National Socialist government, but the Nazi policy of occupation created the preconditions necessary for putting theoretical models into practice. this was done in complete disregard of pre-existing structures in population, settlement, society, economy, and patterns of traffic. The principal aim consisted in the total transformation of the envisaged Eastern European sphere and the implantation of a new National Socialist social order style in Eastern Europe. Scientific planning not only implied a declaration of war against the very people living in the geographic sphere covered by the plan, but presupposed the existence of war in order to put the plan into practice. In a rare mixture of social science, geography and biology, instruments of science made possible and provoked the social selection and deportation of human beings as well as attempts at 'Germanization' and 'Umvolkung'. It is a well known fact, that deportation and extermination became a brutal reality as an intrinsic ingredient of these planning efforts.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Schleiermacher. 1996. [Not Available].. https://doi.org/10.1002/bewi.19960190213

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Current trends in hematopoietic stem cell transplantation in Europe.

Major changes have occurred in the transplantation of hematopoietic stem cells (HSCs) during the last decade. This report reveals the changes, reflects current status, and provides medium-term projections of HSC transplantation (HSCT) development in Europe. Data on 132 963 patients, 44 165 with allogeneic HSC transplant (33%) and 88 798 with an autologous HSC transplant (67%), collected prospectively from 619 centers by the European Group for Blood and Marrow Transplantation (EBMT) in 35 European countries between 1990 (4234 HSCTs) and 2000 (19 136 HSCTs) illustrate utilization of HSCT. HSCT increased in all European countries and for all indications. There were major differences depending on disease indication and donor type. Transplantation rates (numbers of HSCTs per 10 million inhabitants) varied from less than 1 for some rare indications to 37.7 +/- 4.1 for acute myeloid leukemia in allogeneic HSCT or 95.5 +/- 13.5 for non-Hodgkin lymphoma in autologous HSCT. There were indications with a steady, continuing increase and others with initial increase but subsequent decrease. Projections on medium-term development for each disease based on a weighted sensitivity analysis predict an ongoing increase in allogeneic HSCT except for chronic myeloid leukemia. In autologous HSCT they predict an increase for lymphoproliferative disorders, acute myeloid leukemia, myelodysplastic syndromes, and some solid tumors but a decrease for most solid tumors, acute lymphoid leukemia, and chronic myeloid leukemia. Transplantation rates can be predicted with reasonable sensitivity for most disease indications. Despite marked changes in the rapidly developing field of HSCT, this information on current use, trends, and midterm predictions forms a rational basis for patient counseling and health care planning.

Europe↗